Market Place
Sourcing Support
Prilenia: Huntington`s, ALS Pridopidine Data At AAN 2024
12 Apr 2024 //
BUSINESSWIRE
Prilenia Plans to Submit MAA in the EU for Pridopidine in Huntington’s Disease
12 Mar 2024 //
BUSINESSWIRE
Aural Speech Technology Signaled Slowing of Decline in ALS Patients’ Speech
24 Feb 2023 //
BUSINESSWIRE
Prilenia searches for positive signs in phase 2 ALS fail
23 Feb 2023 //
FIERCE BIOTECH
Prilenia Completes Enrollment Ahead of Schedule in HEALEY ALS Platform Trial
05 Jan 2022 //
BUSINESSWIRE
Prilenia Receives FTD for Pridopidine for Huntington’s Disease
17 Nov 2021 //
BUSINESSWIRE
Prilenia Announces First Patient Enrolled for Pridopidine Ph2/3 Platform
08 Jan 2021 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.